Identification of epitopes on cytochrome P450 3A4/5 recognized by monoclonal antibodies

Archives of Biochemistry and Biophysics

Volumn 414, Issue 2, 2003, Pages 244-254

  Parimoo, Bhama ^a   Mishin, Vladimir M ^a   Busch, Christine M ^a   Thomas, Paul E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Cytochrome P450 3A4 5; Epitope mapping; GST fusion construct; Monoclonal antibodies; Quinine 3 hydroxylation; Western blots

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; QUININE;

ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CATALYSIS; ENZYME ANALYSIS; ENZYME INHIBITION; EXPRESSION VECTOR; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIVER MICROSOME; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; VALIDATION PROCESS; WESTERN BLOTTING;

CINCHONA PUBESCENS; UNIDENTIFIED BACULOVIRUS; VECTORS;

EID: 0038101411     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9861(03)00128-0     Document Type: Article

References (46)

1. Porter T.D., Coon M.J. J. Biol. Chem. 266:1991;13469-13472.
2. Gonzalez F.J. Pharmacol. Ther. 45:1990;1-38.
3. Waxman D.J. Biochem. Pharmacol. 37:1988;71-84.
4. Smith D.A., Jones B.C. Biochem. Pharmacol. 44:1992;2089-2098.
5. J Waxman D. Arch. Biochem. Biophys. 369:1999;11-23.
6. A Wrighton S., Stevens J.C. Crit. Rev. Toxicol. 22:1992;1-21.
7. Reik L.M., Levin W., Ryan D.E., Maines S.L., Thomas P.E. Arch. Biochem. Biophys. 242:1985;365-382.
8. Mei Q., Tang C., Lin Y., Rushmore T.H., Shou M. Drug Metab. Dispos. 30:2002;701-708.
9. Gelboin H.V. Pharmacol. Rev. 45:1993;413-453.
10. Schulz T.G., Thiel R., Neubert D., Brassil P.J., Schulz-Utermoehl T., Boobis A.R., Edwards R.J. Biochem. Biophys. Acta. 1546:2001;143-155.
11. Boobis A.R., J Edwards R., Adams D.A., Davies D.S. Br. J. Clin. Pharmacol. 42:1996;81-89.
12. Wang R.W., Newton D.J., Liu N.Y., Shou M., Rushmore T., Lu A.Y. Drug Metab. Dispos. 27:1999;167-172.
13. Richardson T.H., Griffin K.J., Jung F., Raucy J.L., Johnson E.F. Arch. Biochem. Biophys. 338:1997;157-164.
14. Schulz-Utermoehl T., Mountfield R.J., Bywater R.P., Madsen K., Jorgensen P.N., Hansen K.T. Drug Metab. Dispos. 28. 2000;718-725.
15. Schulz-Utermoehl T., Edwards R.J., Boobis A.R. Drug Metab. Dispos. 28:2000;544-551.
16. Cribb A., Nuss C., Wang R. Drug Metab. Dispos. 23:1995;671-675.
17. Murray B.P., Edwards R.J., Murray S., Singleton A.M., Davies D.S., Boobis A.R. Carcinogenesis. 14:1993;585-592.
18. Nakamura A., Yamamoto Y., Tasaki T., Sugimoto C., Masuda M., Kazusaka A., Fujita S. Drug Metab. Dispos. 23:1995;1268-1273.
19. Dean W.L., Coon M.J. J. Biol. Chem. 252:1977;3255-3261.
20. Fujino T., West D., Park S.S., Gelboin H.V. Pharmacology. 40:1990;301-311.
21. Bourdi M., Chen W., Peter R.M., Martin J.L., Buters J.T., Nelson S.D., Pohl L.R. Chem. Res. Toxicol. 9:1996;1159-1166.
22. Klein R., Zanger U.M., Berg T., Hopf U., Berg P.A. Clin. Exp. Immunol. 118:1999;290-297.
23. Thomas P.E., Bandiera S., Reik L.M., Maines S.L., Ryan D.E., Levin W. Fed. Proc. 46:1987;2563-2566.
24. Wrighton S.A., Ring B.J., Watkins P.B., Vandenbranden M. Mol. Pharmacol. 36:1989;97-105.
25. de StGroth S.F., Scheidegger D. J. Immunol. Methods. 35:1980;1-21.
26. Engvall E. Methods Enzymol. 70:1980;419-439.
27. Parimoo B., Thomas P.E. Arch. Biochem. Biophys. 380:2000;117-125.
28. Belloc C., Baird S., Cosme J., Lecoeur S., Gautier J.C., Challine D., de Waziers I., Flinois J.-P., Beaune P.H. Toxicology. 106:1996;207-219.
29. Towbin H., Staehelin T., Gordon J. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
30. Edwards R.J., Adams D.A., Watts P.S., Davies D.S., Boobis A.R. Biochem. Pharmacol. 56:1998;377-387.
31. Adams D.A., Edwards R.J., Davies D.S., Boobis A.R. Biochem. Pharmacol. 54:1997;189-197.
32. Zhao X.J., Yokoyama H., Chiba K., Wanwimolruk S., Ishizaki T. J. Pharmacol. Exp. Ther. 279:1996;1327-1334.
33. Leeder J.S., Gaedigk A., Lu X.L., Cook V.A. Mol. Pharmacol. 49:1996;234-243.
34. Bjerrum O.J., Heegaard N.H.H. CRC Handbook of Immunoblotting of Proteins. 1988;CRC Press, Boca Raton, FL.
35. Lecoeur S., Andre C., Beaune P.H. Mol. Pharmacol. 50:1996;326-333.
36. Belloc C., Gauffre A., Andre C., Beaune P.H. Pharmacogenetics. 3:1997;181-186.
37. Guengerich F.P. Chem.-Biol. Interact. 106:1997;161-182.
38. Duclos-Vallee J.C., Hajoui O., Yamamoto A.M., Jacz-Aigrain E., Alvarez F. Gastroenterology. 108:1995;470-476.
39. Nakamura A., Yamamoto Y., Tasaki T., Sugimoto C., Masuda M., Kazusaka A., Fujita S. Xenobiotica. 25:1995;1103-1109.
40. Lewis D.F.V. Cytochromes P450, Structure, Function and Mechanism. 1996;Taylor & Francis, London.
41. Hasemann C.A., Kurumbail R.G., Boddupalli S.S., Peterson J.A., Deisenhofer J. Structure. 3:1995;41-62.
42. Wang R.W., Lu A.Y.H. Drug Metab. Dispos. 25:1997;762-767.
43. Shen S., Strobel H.W. Biochemistry. 33:1994;8807-8812.
44. Letawe-Goujon F., Kremers P., Beaune P., Paye M., Gielen J.E. Biochem. Biophys. Res. Commun. 119:1984;744-750.
45. Edwards R.J., Murray B.P., Murray S., Singleton A.M., Davies D.S., Boobis A.R. Biochim. Biophys. Acta. 116:1993;38-46.
46. Ma Y., Thomas M.G., Okamoto M., Bogdanos D.P., Nagl S., Kerkar N., Lopes A.R., Muratori L., Lenzi M., Bianchi F.B., Mieli-Vergani G., Vergani D. J. Immunol. 169:2002;277-285.